Nasopharyngeal metastasis of breast carcinoma with HER 2 discordance: a case report

ANZ J Surg. 2018 May;88(5):508-509. doi: 10.1111/ans.13446. Epub 2016 Feb 22.

Authors

Bridget Copson¹, Upasna Pratap¹, Catriona McLean², Theresa Hayes³

Affiliations

¹ Department of Otolaryngology, Alfred Health, Melbourne, Victoria, Australia.
² Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia.
³ Department of Medical Oncology, South West Oncology, Warrnambool, Victoria, Australia.

PMID: 26909745
DOI: 10.1111/ans.13446

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Breast Neoplasms / pathology*
Breast Neoplasms / surgery
Docetaxel / administration & dosage
Female
Follow-Up Studies
Humans
Mastectomy / methods
Middle Aged
Molecular Targeted Therapy / methods
Nasal Obstruction / diagnosis
Nasal Obstruction / etiology
Nasopharyngeal Neoplasms / diagnostic imaging
Nasopharyngeal Neoplasms / drug therapy*
Nasopharyngeal Neoplasms / secondary*
Rare Diseases
Receptor, ErbB-2 / genetics*
Tomography, X-Ray Computed / methods
Trastuzumab / administration & dosage
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
Docetaxel
ERBB2 protein, human
Receptor, ErbB-2
pertuzumab
Trastuzumab